Detailed TOC of Global Plasma Derived Therapies Market Research Report Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2032
Table of Content
1 Market Definition and Statistical Scope
1.1 Objective of the Study
1.2 Plasma Derived Therapies Market Definition
1.3 Market Scope
1.3.1 Market Segmentation by Type, Downstream Industry and Marketing Channel
1.3.2 Major Geographies Covered (North America, Europe, Asia Pacific, Middle East & Africa, Latin America)
1.4 Years Considered for the Study (2019-2030)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders
2 Research Findings and Conclusion
3 Key Companies? Profile
3.1 Competitive Profile
3.1.1 Global Plasma Derived Therapies Sales and Market Share by Companies
3.1.2 Global Plasma Derived Therapies Revenue and Market Share by Companies
3.2 SA
3.2.1 Brief Introduction of SA
3.2.2 SA Sales, Growth Rate and Global Market Share from 2019-2032
3.2.3 SA Related Products/Service Introduction
3.2.4 SA Business Overview/Recent Development/Acquisitions
3.3 Takeda Pharmaceutical Company Limited
3.3.1 Brief Introduction of Takeda Pharmaceutical Company Limited
3.3.2 Takeda Pharmaceutical Company Limited Sales, Growth Rate and Global Market Share from 2019-2032
3.3.3 Takeda Pharmaceutical Company Limited Related Products/Service Introduction
3.3.4 Takeda Pharmaceutical Company Limited Business Overview/Recent Development/Acquisitions
3.4 Grifols
3.4.1 Brief Introduction of Grifols
3.4.2 Grifols Sales, Growth Rate and Global Market Share from 2019-2032
3.4.3 Grifols Related Products/Service Introduction
3.4.4 Grifols Business Overview/Recent Development/Acquisitions
3.5 Octapharma
3.5.1 Brief Introduction of Octapharma
3.5.2 Octapharma Sales, Growth Rate and Global Market Share from 2019-2032
3.5.3 Octapharma Related Products/Service Introduction
3.5.4 Octapharma Business Overview/Recent Development/Acquisitions
3.6 Pfizer
3.6.1 Brief Introduction of Pfizer
3.6.2 Pfizer Sales, Growth Rate and Global Market Share from 2019-2032
3.6.3 Pfizer Related Products/Service Introduction
3.6.4 Pfizer Business Overview/Recent Development/Acquisitions
3.7 CSL Behring
3.7.1 Brief Introduction of CSL Behring
3.7.2 CSL Behring Sales, Growth Rate and Global Market Share from 2019-2032
3.7.3 CSL Behring Related Products/Service Introduction
3.7.4 CSL Behring Business Overview/Recent Development/Acquisitions
3.8 Biotest AG
3.8.1 Brief Introduction of Biotest AG
3.8.2 Biotest AG Sales, Growth Rate and Global Market Share from 2019-2032
3.8.3 Biotest AG Related Products/Service Introduction
3.8.4 Biotest AG Business Overview/Recent Development/Acquisitions
3.9 Kedrion
3.9.1 Brief Introduction of Kedrion
3.9.2 Kedrion Sales, Growth Rate and Global Market Share from 2019-2032
3.9.3 Kedrion Related Products/Service Introduction
3.9.4 Kedrion Business Overview/Recent Development/Acquisitions
3.10 BPL
3.10.1 Brief Introduction of BPL
3.10.2 BPL Sales, Growth Rate and Global Market Share from 2019-2032
3.10.3 BPL Related Products/Service Introduction
3.10.4 BPL Business Overview/Recent Development/Acquisitions
3.11 ADMA Biologics
3.11.1 Brief Introduction of ADMA Biologics
3.11.2 ADMA Biologics Sales, Growth Rate and Global Market Share from 2019-2032
3.11.3 ADMA Biologics Related Products/Service Introduction
3.11.4 ADMA Biologics Business Overview/Recent Development/Acquisitions
3.12 Kamada Pharmaceuticals
3.12.1 Brief Introduction of Kamada Pharmaceuticals
3.12.2 Kamada Pharmaceuticals Sales, Growth Rate and Global Market Share from 2019-2032
3.12.3 Kamada Pharmaceuticals Related Products/Service Introduction
3.12.4 Kamada Pharmaceuticals Business Overview/Recent Development/Acquisitions
3.13 SK Plasma
3.13.1 Brief Introduction of SK Plasma
3.13.2 SK Plasma Sales, Growth Rate and Global Market Share from 2019-2032
3.13.3 SK Plasma Related Products/Service Introduction
3.13.4 SK Plasma Business Overview/Recent Development/Acquisitions
4 Global Plasma Derived Therapies Market Segmented by Type
4.1 Global Plasma Derived Therapies Sales, Revenue and Growth Rate by Type 2019-2032
4.2 Immunoglobulin
4.3 Coagulation factors
4.4 Albumin
4.5 Others
5 Global Plasma Derived Therapies Market Segmented by Downstream Industry
5.1 Global Plasma Derived Therapies Sales, Revenue and Growth Rate by Downstream Industry 2019-2032
5.2 Hemophilia
5.3 Primary immunodeficiency disease
5.4 Idiopathic thrombocytopenic purpura
5.5 Others
6 Plasma Derived Therapies Industry Chain Analysis
6.1 Value Chain Status
6.2 Upstream Raw Material Analysis
6.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
6.4 Distributors/Traders
6.5 Downstream Major Customer Analysis (by Region)
6.6 Value Chain Under Regional Conflicts
7 The Development and Dynamics of Plasma Derived Therapies Market
7.1 Driving Factors of the Market
7.2 Factors Challenging the Market
7.3 Opportunities of the Global Plasma Derived Therapies Market (Regions, Growing/Emerging Downstream Market Analysis)
7.4 Technology Status and Developments in the Plasma Derived Therapies Market
7.5 Industry News
7.6 Market Investment Scenario Strategic Recommendations
7.7 COVID-19 Impact on Plasma Derived Therapies Industry
7.7.1 Plasma Derived Therapies Business Impact Assessment - Covid-19
7.7.2 Supply Chain Challenges
7.7.3 Market Trends and Potential Opportunities of Plasma Derived Therapies in the COVID-19 Landscape
7.8 Industry SWOT Analysis
8 Global Plasma Derived Therapies Market Segmented by Geography
8.1 Global Plasma Derived Therapies Revenue and Market Share by Region 2019-2032
8.2 Global Plasma Derived Therapies Sales and Market Share by Region 2019-2032
9 North America
9.1 North America Plasma Derived Therapies Sales, Price, Revenue, Gross Margin (%) and Gross Analysis from 2019-2032
9.2 North America Plasma Derived Therapies Sales Analysis from 2019-2032
9.3 North America Plasma Derived Therapies Import and Export from 2019-2032
9.4 North America Plasma Derived Therapies Market by Country
9.4.1 North America Plasma Derived Therapies Sales by Country (2019-2032)
9.4.2 North America Plasma Derived Therapies Revenue by Country (2019-2032)
9.4.3 United States Plasma Derived Therapies Sales and Growth (2019-2032)
9.4.4 Canada Plasma Derived Therapies Sales and Growth (2019-2032)
10 Europe
10.1 Europe Plasma Derived Therapies Sales, Price, Revenue, Gross Margin (%) and Gross Analysis from 2019-2032
10.2 Europe Plasma Derived Therapies Sales Analysis from 2019-2032
10.3 Europe Plasma Derived Therapies Import and Export from 2019-2032
10.4 Europe Plasma Derived Therapies Market by Country
10.4.1 Europe Plasma Derived Therapies Sales by Country (2019-2032)
10.4.2 Europe Plasma Derived Therapies Revenue by Country (2019-2032)
10.4.3 Germany Plasma Derived Therapies Sales and Growth (2019-2032)
10.4.4 UK Plasma Derived Therapies Sales and Growth (2019-2032)
10.4.5 France Plasma Derived Therapies Sales and Growth (2019-2032)
10.4.6 Italy Plasma Derived Therapies Sales and Growth (2019-2032)
10.4.7 Spain Plasma Derived Therapies Sales and Growth (2019-2032)
10.4.8 Russia Plasma Derived Therapies Sales and Growth (2019-2032)
10.4.9 Netherlands Plasma Derived Therapies Sales and Growth (2019-2032)
10.4.10 Turkey Plasma Derived Therapies Sales and Growth (2019-2032)
10.4.11 Switzerland Plasma Derived Therapies Sales and Growth (2019-2032)
10.4.12 Sweden Plasma Derived Therapies Sales and Growth (2019-2032)
11 Asia Pacific
11.1 Asia Pacific Plasma Derived Therapies Sales, Price, Revenue, Gross Margin (%) and Gross Analysis from 2019-2032
11.2 Asia Pacific Plasma Derived Therapies Sales Analysis from 2019-2032
11.3 Asia Pacific Plasma Derived Therapies Import and Export from 2019-2032
11.4 Asia Pacific Plasma Derived Therapies Market by Country
11.4.1 Asia Pacific Plasma Derived Therapies Sales by Country (2019-2032)
11.4.2 Asia Pacific Plasma Derived Therapies Revenue by Country (2019-2032)
11.4.3 China Plasma Derived Therapies Sales and Growth (2019-2032)
11.4.4 Japan Plasma Derived Therapies Sales and Growth (2019-2032)
11.4.5 South Korea Plasma Derived Therapies Sales and Growth (2019-2032)
11.4.6 Australia Plasma Derived Therapies Sales and Growth (2019-2032)
11.4.7 India Plasma Derived Therapies Sales and Growth (2019-2032)
11.4.8 Indonesia Plasma Derived Therapies Sales and Growth (2019-2032)
11.4.9 Philippines Plasma Derived Therapies Sales and Growth (2019-2032)
11.4.10 Malaysia Plasma Derived Therapies Sales and Growth (2019-2032)
12 Latin America
12.1 Latin America Plasma Derived Therapies Sales, Price, Revenue, Gross Margin (%) and Gross Analysis from 2019-2032
12.2 Latin America Plasma Derived Therapies Sales Analysis from 2019-2032
12.3 Latin America Plasma Derived Therapies Import and Export from 2019-2032
12.4 Latin America Plasma Derived Therapies Market by Country
12.4.1 Latin America Plasma Derived Therapies Sales by Country (2019-2032)
12.4.2 Latin America Plasma Derived Therapies Revenue by Country (2019-2032)
12.4.3 Brazil Plasma Derived Therapies Sales and Growth (2019-2032)
12.4.4 Mexico Plasma Derived Therapies Sales and Growth (2019-2032)
12.4.5 Argentina Plasma Derived Therapies Sales and Growth (2019-2032)
13 Middle East & Africa
13.1 Middle East & Africa Plasma Derived Therapies Sales, Price, Revenue, Gross Margin (%) and Gross Analysis from 2019-2032
13.2 Middle East & Africa Plasma Derived Therapies Sales Analysis from 2019-2032
13.3 Middle East & Africa Plasma Derived Therapies Import and Export from 2019-2032
13.4 Middle East & Africa Plasma Derived Therapies Market by Country
13.4.1 Middle East & Africa Plasma Derived Therapies Sales by Country (2019-2032)
13.4.2 Middle East & Africa Plasma Derived Therapies Revenue by Country (2019-2032)
13.4.3 Saudi Arabia Plasma Derived Therapies Sales and Growth (2019-2032)
13.4.4 UAE Plasma Derived Therapies Sales and Growth (2019-2032)
13.4.5 Egypt Plasma Derived Therapies Sales and Growth (2019-2032)
13.4.6 South Africa Plasma Derived Therapies Sales and Growth (2019-2032)
14 Global Plasma Derived Therapies Market Forecast by Geography, Type, and Downstream Industry 2032-2030
14.1 Forecast of the Global Plasma Derived Therapies Market from 2032-2030 by Region
14.2 Global Plasma Derived Therapies Sales and Growth Rate Forecast by Type (2032-2030)
14.3 Global Plasma Derived Therapies Sales and Growth Rate Forecast by Downstream Industry (2032-2030)
14.4 Plasma Derived Therapies Market Forecast Under COVID-19
15 Appendix
15.1 Methodology
15.2 Research Data Source
